Name,Entry date,Dataset version,Author/Contact person,Short description,Partner,Model type/method,Model,Model version,Documentation,Sector,Keywords,SSP,RCP,GCM,Variables and units,Time start,Time end,Time resolution,Spatial coverage,Spatial resolution unit Europe,Spatial resolution Rest of World,Spatial projection,Data type,File format,Recommended citation,Other comments;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
Valuation of heat related mortality risk,22092021,NA,Iva Zverinova,Monetary impacts of premature mortality due to heat waves,CHARLES UNIVERSITY,Questionnaire survey estimate,Interval-data model willingness to pay estimates; Benefit transfer based on the value per statistical life figure from the interval-data model,NA,NA,Health,Value per Statistical Life; monetary impacts; heat waves; climate change; premature mortality; socio-economic analysis,NA,RCP2.6; RCP4.5; RCP8.5,NA,Monetary impacts of premature mortality (billion PPS Euro); VSL heat wave context; based on income-adjusted benefit transfer (in PPS Eur; in nominal Euro); VSL estimate from the surveys (in PPS Euro; in nominal Euro),2030,2090,Decadal,Spain and the UK (survey); EU (simulation),European regions: Northern Europe (Denmark; Iceland; Finland; Norway; Sweden); Eastern Europe (Estonia; Hungary; Latvia; Lithuania; Romania; Slovakia; Poland); Central Europe (Austria; Czech Republic; Germany; Switzerland); Western Europe (Belgium; France; Ireland; Netherlands; Luxembourg; United Kingdom) and Southern Europe (Bulgaria; Croatia; Cyprus; Greece; Italy; Malta; Portugal; Slovenia; Spain); country,NA,NA,NA,XLS,M. Scasny; W.W.J. Botzen; M. Smid; A. Alberini; A. Chiabai; J. Hroudova; P. Ignjacevic; O. Kuik; M. Kryl; V. Maca; M. Neumann; J. Spadaro; I. Zverinova (2020). D2.6 Non-market impacts: health. Deliverable of the H2020 COACCH project.,NA
Valuation of protection measures against spread of ticks due to climate change and tick-borne diseases,22092021,NA,Iva Zverinova,Preferences for public programmes against spread of ticks due to climate change and a new vaccine against Lyme disease; prevalence of tick-borne diseases and exposure to ticks,CHARLES UNIVERSITY,Questionnaire survey estimate,Interval-data model willingness to pay estimates from double-bounded dichotomous choice; Prevalences and rates based on contingency tables; Random-effect probit model willingness to pay estimates from discrete choice experiments ,NA,NA,Health,vaccine; tick-borne encephalitis; Lyme disease; prevalences of tick-borne diseases; climate change; willingness to pay; socio-economic analysis,NA,NA,NA,Prevalence of lyme disease (%); Prevalence of tick-borne encephalitis (%); Prevalence of another tick-borne disease (%); Percentages of people who have had a tick (%); Frequency of tick bites (percentages from respondents who have had a tick); Rate of tick-borne encephalitis vaccination (%);  Rate of tick-borne encephalitis vaccination of children (%); Percentages of people who will likely get tick-borne encephalitis vaccine when the effectiveness of the vaccine is over (%); Willingness to pay for lyme disease vaccine for respondents themselves from double-bounded dichotomous choice (in PPS EUR); Willingness to pay for combined vaccine against lyme disease and encephalitis for respondents themselves  from double-bounded dichotomous choice (in PPS EUR); Willingness to pay for lyme disease vaccine for respondents themselves from double-bounded dichotomous choice (in nominal EUR); Willingness to pay for combined vaccine against lyme disease and encephalitis for respondents themselves from double-bounded dichotomous choice (in nominal EUR); Willingness to pay for lyme disease or combined lyme disease-encephalitis vaccine for respondents themselves from double-bounded dichotomous choice (in nominal EUR); Willingness to pay for lyme disease or combined lyme disease-encephalitis vaccine for respondent’s spouse from double-bounded dichotomous choice (in nominal EUR); Willingness to pay for lyme disease or combined lyme disease-encephalitis vaccine for respondent’s children from double-bounded dichotomous choice (in nominal EUR); Willingness to pay for lyme disease or combined lyme disease-encephalitis vaccine for respondents themselves by rate of state contribution from double-bounded dichotomous choice (in nominal EUR); Willingness to pay for lyme disease or combined lyme disease-encephalitis vaccine for respondents themselves by rate of state contribution from double-bounded dichotomous choice (in PPS EUR); Willingness to pay for a new programme that will reduce spread of ticks from discrete choice experiments (in PPS EUR); Willingness to pay for a new programme that will reduce spread of ticks from discrete choice experiments  (in nominal EUR); Willingness to pay for a new programme that will provide tick repellents for free of charge for every citizen from discrete choice experiments (in PPS EUR); Willingness to pay for a new programme that will provide tick repellents for free of charge for every citizen from discrete choice experiments  (in nominal EUR); Willingness to pay more for a new programme that will provide vaccine against tick-borne diseases under scenario with current number of ticks from discrete choice experiments (in PPS EUR); Willingness to pay more for a new programme that will provide vaccine against tick-borne diseases under scenario with 25% more ticks due to climate change from discrete choice experiments (in PPS EUR); Willingness to pay more for a new programme that will provide vaccine against tick-borne diseases under scenario with 50% more ticks due to climate change from discrete choice experiments (in PPS EUR),2019,2019,Year of the survey,Austria; the Czech Republic; Slovakia,Austria; the Czech Republic; Slovakia,NA,NA,NA,XLS,M. Scasny; W.W.J. Botzen; M. Smid; A. Alberini; A. Chiabai; J. Hroudova; P. Ignjacevic; O. Kuik; M. Kryl; V. Maca; M. Neumann; J. Spadaro; I. Zverinova (2020). D2.6 Non-market impacts: health. Deliverable of the H2020 COACCH project.,NA;;;;;;;;